Cargando…
MGMT-Methylation in Non-Neoplastic Diseases of the Central Nervous System
Quantifying O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation plays an essential role in assessing the potential efficacy of alkylating agents in the chemotherapy of malignant gliomas. MGMT promoter methylation is considered to be a characteristic of subgroups of certain malignanc...
Autores principales: | Teuber-Hanselmann, Sarah, Worm, Karl, Macha, Nicole, Junker, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068191/ https://www.ncbi.nlm.nih.gov/pubmed/33917711 http://dx.doi.org/10.3390/ijms22083845 |
Ejemplares similares
-
Myelination in Multiple Sclerosis Lesions Is Associated with Regulation of Bone Morphogenetic Protein 4 and Its Antagonist Noggin
por: Harnisch, Kim, et al.
Publicado: (2019) -
Syphilitic Gummata in the Central Nervous System: A Narrative Review and Case Report about a Noteworthy Clinical Manifestation
por: Barthel, Lennart, et al.
Publicado: (2021) -
Modulation of the Complement System by Neoplastic Disease of the Central Nervous System
por: Yarmoska, Steven K., et al.
Publicado: (2021) -
Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023) -
Platelet-derived growth factor (PDGF) in neoplastic and non-neoplastic cystic lesions of the central nervous system and in the cerebrospinal fluid.
por: Nistér, M., et al.
Publicado: (1994)